Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways (Q46966395): Preview

Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways (Q46966395)
scientific article published in February 2006

Language:

Current Data About Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways

(P31)

(Q13442814)

(P248)
(P698)	16505118
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16505118

(P304)

430-437

(P248)
(P698)	16505118
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16505118

(P433)

(P248)
(P698)	16505118
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16505118

(P478)

(P248)
(P698)	16505118
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16505118

(P577)

Wednesday, February 1, 2006

(P248)
(P698)	16505118
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16505118

(P921)

(Q18556110)

(P887)

(Q424771)

(P887)

(Q189159)

(P887)

(P1433)

(Q2363144)

(P248)
(P698)	16505118
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16505118

(P1476)

"Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways" (language: en)

(P248)
(P698)	16505118
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16505118

(P2093)

ShouWei Han

(P1545)	1

(P248)
(P698)	16505118
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16505118

Jesse Roman

(P1545)	2

(P248)
(P698)	16505118
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16505118

other details

description	scientific article published in February 2006

External Links

(P356)	10.1158/1535-7163.MCT-05-0347
(P698)	16505118